PNC Financial Services Group
FENC icon

PNC Financial Services Group’s Fennec Pharmaceuticals FENC Stock Holding History

PNC Financial Services Group’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.93K Buy
645
+135
+26% +$1.1K ﹤0.01% 4262
2026
Q1 		$3.14K Sell
510
-127
-20% -$981 ﹤0.01% 4445
2025
Q4 		$4.91K Sell
637
-331
-34% -$2.72K ﹤0.01% 4239
2025
Q3 		$9.06K Buy
968
+23
+2% +$199 ﹤0.01% 3978
2025
Q2 		$7.84K Hold
945
– – ﹤0.01% 3973
2025
Q1 		$5.75K Hold
945
– – ﹤0.01% 4013
2024
Q4 		$5.97K Buy
+945
New +$4.84K ﹤0.01% 3979
2024
Q3 		– Sell
-112
Closed -$684 – 4838
2024
Q2 		$684 Buy
+112
New +$930 ﹤0.01% 4484
2024
Q1 		– Sell
-87
Closed -$976 – 4729
2023
Q4 		$976 Buy
+87
New +$721 ﹤0.01% 4320

Other funds holding FENC

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HFM
Hartford Financial Management Hartford, Connecticut $448M AUM 32.11% 1-Year Est. Return
EC
Eleva Capital Paris, France $343M AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PNC Financial Services Group's FENC Position: Q2 2026 in Review

PNC Financial Services Group increased its Fennec Pharmaceuticals (FENC) stake by 26% in Q2 2026, buying an estimated $1.1K and bringing the position to 645 shares worth $6.93K. The position accounts for ﹤0.01% of the portfolio, ranked #4262.

PNC Financial Services Group first reported a position in FENC in Q4 2023 and has held it in 9 quarters since. The position peaked at $9.06K in Q3 2025. 33 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • PNC Financial Services Group held 645 shares of Fennec Pharmaceuticals worth $6.93K as of Q2 2026.
  • PNC Financial Services Group bought 135 Fennec Pharmaceuticals shares in Q2 2026, an estimated $1.1K.
  • Fennec Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4262 holding.
  • PNC Financial Services Group first reported a position in Fennec Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • PNC Financial Services Group's Fennec Pharmaceuticals position peaked at $9.06K in Q3 2025.
  • 33 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.